The UC Berkeley School of Public Health (SPH) is excited to announce the launch of the Gilead Fellowship for the Advancement of Global Public Health. This new fellowship award supports international students from low and middle income countries who would like to pursue a Masters of Public Health (MPH) in Epidemiology or Infectious Diseases and Vaccinology. This exciting new capacity-building program will provide support to five international Fellows from developing countries as they complete an 18-month Masters in Public Health (MPH) degree with a concentration in Global Health. Gilead Fellows will focus on critical areas of global health including infectious diseases, vaccinology, and epidemiology as they relate to challenges faced by their home countries as well as worldwide. These awards are made possible thanks to the generous support of Gilead Sciences, Inc, which strives to transform and simplify care for people with life-threatening illnesses around the world. The program will be overseen by the UC Berkeley Center for Global Public Health (CGPH) based at SPH. The multi-faceted mission of CGPH includes the development of global health education and training initiatives for the UC Berkeley campus and beyond.
Congratulations to the Recipients of our 2019 Gilead Fellowship for the Advancement of Global Public Health!
The UC Berkeley Center for Global Public health is excited to welcome and congratulate our five new Gilead Fellows! Over the next year and a half, our fellows will pursue a Masters of Public Health (MPH) in Epidemiology or Infectious Diseases and Vaccinology. These awards are made possible thanks to the generous support of Gilead Sciences, Inc, which strives to transform and simplify care for people with life-threatening illnesses around the world. The program will be overseen by the UC Berkeley Center for Global Public Health (CGPH) based at SPH.
Tinkhani is a first year MPH – Epidemiology student at UC Berkeley. For the past six years he has been active in medical practice, senior management, and clinical research. He completed his medical training at University of Malawi College of Medicine in 2011 before serving as a district medical officer within the Ministry of Health in Malawi. His experience of treating patients in rural communities in Malawi led him to embrace a deeper interest in public health approaches to infectious disease prevention. He has vested research interests in global health, prevention and control of infectious diseases including HIV/AIDS, TB and malaria. This passion for infectious disease epidemiology led him to join HIV/AIDS prevention clinical research at the University of North Carolina research Project in Lilongwe where he is a local lead co-investigator under the HIV Prevention Clinical Trials Network (HPTN). For the past three years, he has been studying the development of novel HIV prevention options for women in Sub –Saharan Africa who are disproportionately affected by HIV. These PrEP HIV studies are HPTN 077, a phase 2 study to evaluate safety of injectable Cabotegravir for HIV prevention, HPTN 084, a Phase III clinical trial to evaluate the efficacy of injectable Cabotegravir for prevention of HIV compared to oral Pre-exposure prophylaxis (Truvada), and the AMP study that is evaluating VRC01, a broadly neutralizing monoclonal antibody, for HIV prevention. The Global health Gilead fellowship at UC Berkeley came off as a great opportunity to advance his skills and knowledge in infectious disease epidemiology to improve the health of all people at a global scale.
Bryan Tegomoh, MD
Bryan is a UC Berkeley MPH student in Infectious Diseases & Vaccinology. His interest in this track were inspired by his experiences providing care as a physician in a resource-limited setting in Cameroon. Today he seeks ways to improve population health in a more holistic approach, taking the practice of medicine from an individual to a population level. He obtained his medical degree with distinction from the University of Yaoundé I, Cameroon, and was previously a visiting researcher in Pediatric Infectious Disease and Molecular Microbiology at Washington University School of Medicine in St. Louis, Missouri, in Dr. Audrey Odom John’s Lab, with primary research goal to understand the biological role of specific metabolic pathways in the malaria parasite in order to identify new antimalarial drug targets and biomarkers for a breath-based diagnostic test for malaria. He is dedicated to alleviating the immense burden of infectious diseases in underserved communities across the globe.
Infectious Diseases have fascinated me since my first years of medical school. Not only for the vast and rich science permeating the field, but for the unique opportunity to connect with a myriad of diverse patient populations and realities from around the globe. For the past 8 years, after finishing my residency and obtaining my phD in virology, I have been working in hospital epidemiology / infection control and in direct patient-care at a public reference center for viral hepatitis and HIV. In Brazil, practicing within a universal-access public healthcare system is both vastly rewarding and particularly challenging. This opportunity to expand my understanding of the dynamics of public health in a global perspective will be invaluable!
José Victor Zambrana
José Victor Zambrana has worked in the field of arboviral diseases since 2011; he is currently a research assistant at the Sustainable Sciences Institute where he has worked mainly in the development and optimization of in-house diagnostic methods for Zika and Dengue. He learned the basics of data analysis in a self-taught way, a tool that has allowed him to analyze epidemiological information for peer-reviewed research. In his spare time, he reads world literature, enjoys languages and Indie music. He graduated from UNAN Managua with a degree in Clinical Bioanalysis.
Daphine Kaana Namara MD
Namara is a mid-level Medical Doctor interested in the interaction of Global Health and cutting edge clinical research in solving today's leading Tropical and Infectious Diseases. She has 3 years combined experience in Infectious Disease care and treatment specifically for HIV and Tuberculosis patients in developing countries. She currently serves as a Medical Officer and Technical Lead for the HIV/TB co-infection clinic at Makerere University Joint AIDS Program (MJAP) - a PEPFAR funded organization. Namara has been responsible for care and treatment, and follow up for over 3,000 patients annually during her time at MJAP in Kampala, Uganda. She envisions an evolving career that places her at the heart of shaping patient care, and supporting the improvement of Global Health Policies and implementation in Uganda and abroad. Namara is a Dean’s List graduate of Makerere University School of Medicine in Kampala.